Related Experiment Video
Updated: Jul 27, 2026
04:04
Blind Endotracheal Intubation in Neonatal Rabbits
Published on: February 26, 2021
5.8K
Teixobactin Provides Protection against Inhalation Anthrax in the Rabbit Model
William S Lawrence1,2, Jennifer E Peel1, Satheesh K Sivasubramani3
1Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Pathogens (Basel, Switzerland)
|September 25, 2020
Summary
Teixobactin demonstrated 100% survival in rabbits against inhalation anthrax. This new antibiotic effectively resolved bacteremia and reduced bacterial load, showing promise for treating anthrax infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Antibiotics are crucial for treating Bacillus anthracis infections.
- Multidrug-resistant B. anthracis strains pose a bioweapon threat, necessitating novel therapeutics.
- Teixobactin is a recently discovered antibiotic with potential therapeutic applications.
Purpose of the Study:
- To evaluate the efficacy of teixobactin against inhalation anthrax.
- To assess teixobactin's protective effects in an adult rabbit model.
Main Methods:
- New Zealand White rabbits were infected with B. anthracis Ames spores via inhalation.
- Teixobactin treatment was initiated upon detecting B. anthracis protective antigen.
- Levofloxacin served as a positive control for comparison.
Main Results:
- Teixobactin treatment resulted in 100% survival of infected rabbits.
- Bacteremia was fully resolved within 24-48 hours post-treatment.
- Significantly reduced bacterial/spore loads and decreased tissue pathology were observed.
Conclusions:
- Teixobactin is effective in protecting against lethal inhalation anthrax in a rabbit model.
- These findings highlight teixobactin's potential as a viable therapeutic agent for anthrax.
